Primary coronary angioplasty vs thrombolysis for the management of acute myocardial infarction in elderly patients

JAMA

Volumn 282, Issue 4, 1999, Pages 341-348

  Berger, Alan K ^a,b,d   Schulman, Kevin A ^a   Gersh, Bernard J ^a   Pirzada, Sarmad ^c   Breall, Jeffrey A ^a   Johnson, Ayah E ^a   Every, Nathan R ^c  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b Delmarva Foundation for Medical Care Inc   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANISTREPLASE; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ACUTE HEART INFARCTION; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY REPERFUSION; ELECTROCARDIOGRAM; FEMALE; FIBRINOLYTIC THERAPY; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

EID: 0033612717     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.282.4.341     Document Type: Article

References (23)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative review of early mortality and major morbidity results from all randomised trials of more that 1000 patients. Lancet. 1994;343:311-322.
2. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA. 1997;278:2093-2098.
3. Every NR, Parsons LS, Hlatky M, Martin JS, Weaver WD. A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. N Engl J Med. 1996;335:1253-1260.
4. Tiefenbrunn AJ, Chandra NC, French WJ, et al. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 1998;31:1240-1245.
5. Vogel RA. HCFA's Cooperative Cardiovascular Project: a nationwide quality assessment of acute myocardial infarction. Clin Cardiol. 1994;17:354-356.
6. Jencks SF, Wilensky GR. The health care quality improvement initiative. JAMA. 1992;268:900-903.
7. Hochman JS, Gersh BJ. Acute myocardial infarction: complications. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. Philadelphia, Pa: Lippincott-Raven; 1998:437-480.
8. Marciniak TA, Ellerbeck EF, Radford MJ, et al. Improving the quality of care for Medicare patients with acute myocardial infarction. JAMA. 1998;279:1351-1357.
9. American Hospital Association. The Annual Survey of Hospitals. Chicago, Ill: American Hospital Association; 1994.
10. Fleming C, Fisher ES, Chang CH, Bubolz TA, Malenka DJ. Study outcomes and hospital utilization in the elderly: the advantages of a merged data base for Medicare and Veterans Affairs hospitals. Med Care. 1992;30:377-391.
11. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York, NY: Oxford University Press; 1989.
12. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53: 457-481.
13. Cox DR. Regression models and life tables. J R Stat Soc B. 1972;34:187-192.
14. Normand ST, Glickman ME, Sharma RG, McNeil BJ. Using admission characteristics to predict short-term mortality from myocardial infarction in elderly patients: results from the Cooperative Cardiovascular Project. JAMA. 1996; 275:1322-1328.
15. SAS System for Windows [computer program]. Version 6.12. Cary, NC: SAS Institute; 1996.
16. Ribideiro EE, Silva LA, Carneiro R, et al. Randomized trial of direct coronary angioplasty versus intravenous streptokinase in acute myocardial infarction. J Am Coll Cardiol. 1993;22:376-380.
17. Stone GW, Grines CL, Vlietstra R, et al. Primary angioplasty is the preferred therapy for women and the elderly with acute myocardial infarction: results of the Primary Angioplasty in Myocardial Infarction (PAMI) trial [abstract]. J Am Coll Cardiol. 1993;21:330A.
18. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med. 1997;336:1621-1628.
19. Ellis SG, Weintraub W, Holmes D, Shaw R, Block PC, King SB III. Relation of operator volume and experience to procedural outcome of percutaneous coronary revascularization at hospitals with high interventional volumes. Circulation. 1997;95:2479-2484.
20. Jollis JG, Peterson ED, Stafford JA, DeLong ER, Muhlbaier LH, Mark DB. Relationship beween physician and hospital angioplasty volume and outcome in elderly patients. Circulation. 1997;95:2485-2491.
21. Thiemann DR, Oetgen WJ, Powe NR. Acute MI patients admitted directly to cardiac centers have lower long-term mortality: a HCFA Cooperative Cardiovascular Project study [abstract]. Circulation. 1997;96 (supp 1):562.
22. Ryan TJ, Anderson JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 1996;28:1328-1348.
23. Krumholz HM, Murillo J, Chen J, Radford MJ, Ellerbeck EF, Wang Y. Thrombolytic therapy for the treatment of eligible elderly Medicare beneficiaries with acute myocardial infarction. JAMA. 1997;277:1683-1688.